Mailey Brian, Saba Salim, Baker Jennifer, Tokin Christopher, Hickey Sean, Wong Ryan, Wallace Anne M, Cohen Steven R
From the *Division of Plastic Surgery, School of Medicine, University of California San Diego; and †Faces+, San Diego, CA.
Ann Plast Surg. 2013 Apr;70(4):410-5. doi: 10.1097/SAP.0b013e31827e5353.
The role of regenerative cells in adult human fat is still unfolding. At present, limited clinical studies comparing patient satisfaction with cell-enriched fat transfer (CEFT) to conventional autologous fat transfer (AFT) for aesthetic indications have been performed. Herein, we present our data obtained from patient satisfaction questionnaires.
Patients undergoing fat grafting received AFT or CEFT. Study participants were surveyed for overall satisfaction, symmetry, deformity, scarring, and pigmentation. Hospital charts were reviewed for complications, and patient survey responses between the groups were compared.
Between January 2009 and September 2011, 36 patients had 6-months follow-up and were mailed surveys. Of these, 17 (12 CEFT and 5 AFT) returned completed Patient Satisfaction Rating surveys. At a median follow-up time of 10.7 months, the overall mean satisfaction rate was 5.2 of 6 (5.3 vs 5.0 for CEFT and AFT, respectively, P = 0.42). There were no significant differences about deformity (5.1 vs 4.7, P = 0.50), symmetry (4.5 vs 5.0, P = 0.48), or scarring (5.3 vs 4.5, P = 0.23). However, pigmentation was improved in the CEFT vs the AFT groups (P < 0.001). No patients in the AFT group noted skin pigmentation improvement, whereas 7 of 12 receiving CEFT noted improvement in skin pigmentation.
Cell-enriched fat transfer to the face and body of aesthetic patients produces high satisfaction rates. Our preliminary data demonstrates similar satisfaction with regard to symmetry, scarring, and deformity in patients treated with CEFT versus AFT, without any complications. Unexpectedly, a clinical and statistical improvement in pigmentation was seen for patients treated with CEFT over AFT. Further studies need to be done to better understand this phenomenon.
再生细胞在成人脂肪中的作用仍在不断揭示。目前,针对美学适应症,比较富含细胞的脂肪移植(CEFT)与传统自体脂肪移植(AFT)患者满意度的临床研究有限。在此,我们展示从患者满意度调查问卷中获得的数据。
接受脂肪移植的患者接受AFT或CEFT。对研究参与者进行总体满意度、对称性、畸形、瘢痕形成和色素沉着方面的调查。查阅医院病历以了解并发症情况,并比较两组之间的患者调查回复。
在2009年1月至2011年9月期间,36例患者接受了6个月的随访并收到邮寄的调查问卷。其中,17例(12例CEFT和5例AFT)返回了完整的患者满意度评分调查问卷。在中位随访时间10.7个月时,总体平均满意度为6分中的5.2分(CEFT和AFT分别为5.3分和5.0分,P = 0.42)。在畸形(5.1分对4.7分,P = 0.50)、对称性(4.5分对5.0分,P = 0.48)或瘢痕形成(5.3分对4.5分,P = 0.23)方面没有显著差异。然而,CEFT组与AFT组相比色素沉着有所改善(P < 0.001)。AFT组中没有患者注意到皮肤色素沉着改善,而接受CEFT的12例患者中有7例注意到皮肤色素沉着改善。
对美学患者进行面部和身体的富含细胞的脂肪移植产生了较高的满意度。我们的初步数据表明,CEFT治疗的患者与AFT治疗的患者在对称性、瘢痕形成和畸形方面的满意度相似,且无任何并发症。出乎意料的是,与AFT相比,CEFT治疗的患者在色素沉着方面有临床和统计学上的改善。需要进一步研究以更好地理解这一现象。